Stock·NASDAQ·Financial Services
Sharplink Inc. (SBET)
- Market cap
- $1.66B
- Dividend yield
- None
- Street target
- $14.00median of 8 analysts
- 52-week range
- $4.46 $14.52
SBET stock forecast today
Where SBET stands today, and what CleaRank Financial AI makes of it.
SBET at a glance
Sharplink Inc. (SBET): Hold, 41/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($8.54 and $7.29).
- Insiders Insiders sold $48.9M and bought $4.0M over the last 18 months.
Figures as of October 26, 2026.
CleaRank Financial AI
SBET, also known as Sharplink Inc., earns a Hold rating from CleaRank with a model score of 41/100.
Analysts lift the score the most: 8 of 8 rate the stock a buy, and the median target is 95.0% above the price. The trend is down, with the stock 15.88% below its 50-day average of $8.54 and 1.49% below its 200-day average of $7.29. Across the past year, the price has fallen 48.42%.
Only on CleaRank
Figures we compute ourselves from SBET's own price, earnings and insider-filing history. Tap one to see it in context.
SBET stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
1/4Price above its 50-day average ›
The price of $7.18 is 15.9% below the 50-day simple moving average of $8.54.Price above its 200-day average ›
The price is 1.5% below the 200-day simple moving average of $7.29.50-day average above the 200-day ›
The 50-day average ($8.54) is 17.1% above the 200-day average ($7.29), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 27% of its 52-week range, between $4.46 and $14.52.
SBET share price
Pick a period: each tab shows how far SBET has moved over it, to the last close.
Today's trading
Where SBET sits inside today's range and its 52-week range.
SBET fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
0/2P/S below the sector median ›
The price-to-sales ratio of 26.64 is 601.1% above the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was -$1.7B on revenue of $62.2M, a net margin of -2,748.9%.
Key statistics
The headline figures for SBET.
As of October 26, 2026, SBET trades at $7.18, with a market value of $1.66B and no P/E ratio (its trailing earnings are negative).
What the numbers say
CleaRank Financial AI's reading of SBET's valuation, growth and risks.
Sharplink Inc. (SBET) cannot be judged on a P/E, which is not meaningful because its earnings per share over the last 12 months are negative. The company's market capitalisation stands at $1.7B.
The company is losing money, with a net margin of -3,406.15% and an operating margin of -2,752.95%, and a return on equity of -183.57%, below the sector median of 13.8%. Growth outpaces the sector: revenue grew 1,553.90% in the latest quarter year on year, against a sector median of 11.7%.
In the most recent report in our data, dated May 8, 2026, SBET posted EPS of -$3.25 versus an estimate of -$0.62, which was weaker than analysts had forecast. Yet the stock moved the other way: it rose 4.30% in the session that followed.
SBET has not beaten the EPS estimate in any of the 2 reports in our data. Earlier, the stock fell 5.01% after the November 12, 2025 report, a miss of 48.46%. Analysts' average EPS estimate for this fiscal year is -$5.08, and -$0.06 for next year.
Day-to-day volatility is the first thing to plan around: SBET has moved 4.57% on an average session, and its beta against the S&P 500 is 10.59. Until the price regains its moving averages, the trend works against holders. The price is 50.55% below its 52-week high of $14.52.
SBET against the Financial Services sector
How SBET compares with the median Financial Services stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, SBET trades at 26.64x, far above the sector average of 3.80x.
Return vs XLF: Since May 14, 2025, SBET has gained 109.9% against a gain of 9.9% for XLF.
Performance against XLF
SBET and the Financial Services sector fund over the same days.
Revenue and earnings
How much SBET sells, and how much of it becomes profit.
Revenue growth: Revenue grew 666.0% in FY2025 to $28.1M, from $3.7M a year earlier.
Profit margin: The net margin was -2,618.4% in FY2025, down from 275.8% the year before.
Loss-making: SBET lost $735M in FY2025.
Earnings reality check
Did SBET beat what analysts expected, and how did the stock react?
Earnings record: SBET did not beat the analyst estimate in the 2 reports in our data.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| May 8, 2026after close | -$0.62 | -$3.25 | -424.19% | +4.30% | -9.68% |
| Nov 12, 2025after close | $1.30 | $0.67 | -48.46% | -5.01% | -14.69% |
Reports after May 8, 2026 are not yet in our data.
As of October 26, 2026, SBET has beaten the analyst EPS estimate in 0 of the 2 reports in our data; its most recent report in our data, on May 8, 2026, came in 424.19% below the estimate and the stock moved +4.30% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
SBET AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 36.7, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 36.7 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of SBET
The score, the reasoning behind it, and what could move the price next.
Sharplink Inc. (SBET) is in a downtrend. At $7.18, the stock sits 15.88% below its 50-day average of $8.54 and 1.49% below its 200-day average of $7.29. It also sits near the bottom of its 52-week range: the price is 60.99% above the low of $4.46 and 50.55% below the high of $14.52. The 50-day average is still 17.12% above the 200-day, so the averages have yet to reflect the weaker price.
The 14-day RSI of 36.7 is in the bearish zone, above the oversold line, and the MACD line is negative. The short and long run point different ways: the price fell 25.44% over the past month, rose 12.54% over the past three months and fell 48.42% over the past year.
Rating reaffirmed ›
B. Riley Securities kept its Buy rating on September 22, 2026.
Source: Analyst action, B. Riley Securities, September 22, 2026
Earnings miss, but the stock rose ›
The May 8, 2026 report missed the EPS estimate by 424.19%, and the share price rose 4.30% in the first session after it.
Source: Earnings report, May 8, 2026
- The two closest levels to watch are the 200-day SMA at $7.29, just above the price, and the 52-week low at $4.46, below it.
- With the MACD line negative, the 14-day RSI at 36.7 reads as bearish without reaching oversold territory. Readings above 70 or below 30 would signal stretched momentum in either direction.
- The share price rose 4.30% in the first session after the May 8, 2026 report. Across the 2 reports in our data, SBET beat estimates in 0 of them.
The trend is down, since SBET sits beneath both its 50-day ($8.54) and 200-day ($7.29) averages. A recovery would begin with a move back above the 200-day SMA at $7.29, which is the first level overhead.
The next level below the price is the 52-week low at $4.46. With the RSI in the bearish zone, momentum still leans toward that level.
Technical indicators
Momentum and trend for SBET, from its daily closes.
As of October 26, 2026, with SBET at $7.18, its 14-day RSI is 36.7 (showing bearish momentum without being oversold), its 50-day simple moving average is $8.54 and its 200-day is $7.29.
Calculated by CleaRank on daily closes as of October 26, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What SBET moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 26, 2026, SBET's 1-year correlation of daily returns is +0.18 with S&P 500 (SPY), +0.18 with Nasdaq 100 (QQQ), +0.80 with Bitcoin (BTC) and +0.03 with gold (XAU).
SBET price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
8 of 8 analysts rate it a buy or strong buy, 0 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $14.00 is 95.0% above the price.More buy ratings than three months ago ›
8 of 8 rate it a buy now, against 7 of 7 three months ago.
SBET Wall Street View
12-month price targets
The price, $7.18, sits below every analyst's target.
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 22, 2026 | B. Riley Securities | Maintains | Buy |
| Sep 10, 2026 | Cantor Fitzgerald | Maintains | Overweight |
| Aug 18, 2026 | Canaccord Genuity | Maintains | Buy |
| Jul 31, 2026 | TD Cowen | Maintains | Buy |
| Jul 9, 2026 | Citizens | Maintains | Market Outperform |
| Jul 1, 2026 | Cantor Fitzgerald | Maintains | Overweight |
As of October 26, 2026, 8 Wall Street analysts cover SBET: 8 rate it a buy or strong buy, 0 a hold and 0 a sell or strong sell. Their 12-month price targets range from $8.00 to $30.00. The median SBET price target is $14.00, 95.0% above the price of $7.18.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
SBET trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
SBET trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
SBET moves about 4.6% a day on average, so a stop can fill well past its level. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much SBET tends to move, against the market and on its own.
SBET price history and drawdowns
SBET's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
0/4Average daily move under 2% ›
The price has moved 4.57% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 99.7%, from July 2021 to April 2025; the price is still 99.2% below that peak.Most 1-year holds ended higher ›
31% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $88, against $42,015 in the S&P 500 (SPY).
SBET Drawdowns & Recovery
As of October 26, 2026, SBET's worst peak-to-trough fall over the last 10 years with dividends reinvested was -99.7% (July 2021 to April 2025); it is still 99.2% below that peak, and 31% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into SBET in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: SBET trailed the S&P 500 over this period: $88.25 against $42,015.
A $10,000 investment in SBET in October 2016 would be worth about $88 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to SBET, and which have not.
Strongest month, May: an average of +96.49%, up in 3 of 10 years.
Weakest month, June: an average of -11.72%, up in 4 of 10 years.
This month, October: has averaged -8.07%, up in 2 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, SBET's strongest calendar month has been May (average +96.49%, up in 3 of 10 years) and its weakest June (average -11.72%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
SBET stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in SBET, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in SBET today could grow to about $6,246 by 2030 in the base case, with a 90th-percentile outcome near $22,501 and a 10th-percentile outcome around $1,734. Projections are statistical simulations, not guarantees.
SBET Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $4.48 for SBET by 2030 in the base case, from $7.18 today (0.6x over 4 years). The 10th-percentile path ends near $1.24. These are outcomes of a Monte Carlo simulation run on SBET's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $3.36 | $6.38 | $12.12 | |
| 2028 | $2.29 | $5.67 | $14.04 | |
| 2029 | $1.66 | $5.04 | $15.31 | |
| 2030 | $1.24 | $4.48 | $16.16 |
Method: a lognormal simulation of SBET's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
SBET insider trading
What the people running the company have bought and sold.
SBET insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $4.0M on the open market and sold $48.9M.
As of October 26, 2026, SBET insiders reported 7 open-market sales worth $48.9M and 2 open-market purchases worth $4.0M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 8, 2026 | Joseph Michael Lubin
Director
|
Sell | 5.7M | $47.6M |
| Jul 24, 2026 | Leslie Bernhard
Director
|
Grant | 25.0K | - |
| Jul 24, 2026 | Robert M Gutkowski
Director
|
Grant | 25.0K | - |
| Jul 24, 2026 | Obie Mckenzie
Director
|
Grant | 25.0K | - |
| Jul 2, 2026 | Michael D Camarda
Officer
|
Grant | 377.2K | - |
| Jul 2, 2026 | Joseph Chalom
Chief Executive Officer
|
Grant | 726.3K | - |
| Jul 2, 2026 | Robert Michael Delucia
Chief Financial Officer
|
Grant | 185.7K | - |
| Jul 2, 2026 | Dana Eschenburg Perez, CPA
Officer
|
Grant | 31.4K | - |
| Jul 2, 2026 | Matthew A Sheffield
Chief Investment Officer
|
Grant | 313.9K | - |
| May 12, 2026 | Leslie Bernhard
Director
|
Sell | 12.9K | $95.5K |
| May 12, 2026 | Robert M Gutkowski
Director
|
Sell | 12.9K | $95.5K |
| Apr 15, 2026 | Joseph Michael Lubin
Director
|
Option | 11.8M | $1.2K |
| Apr 10, 2026 | Leslie Bernhard
Director
|
Grant | 11.5K | $75.0K |
| Apr 10, 2026 | Robert M Gutkowski
Director
|
Grant | 11.5K | $75.0K |
| Apr 10, 2026 | Obie Mckenzie
Director
|
Grant | 11.5K | $75.0K |
| Mar 31, 2026 | Robert Michael Delucia
Chief Financial Officer
|
Sell | 2.8K | $17.7K |
| Mar 31, 2026 | Robert Michael Delucia
Chief Financial Officer
|
Grant | 10.9K | - |
| Jan 8, 2026 | Joseph Chalom
Chief Executive Officer
|
Grant | 291.8K | - |
| Jan 8, 2026 | Robert Michael Delucia
Chief Financial Officer
|
Grant | 87.5K | - |
| Sep 30, 2025 | Leslie Bernhard
Director
|
Grant | 1.4K | - |
| Sep 30, 2025 | Robert M Gutkowski
Director
|
Grant | 1.4K | - |
| Sep 30, 2025 | Obie Mckenzie
Director
|
Grant | 1.4K | - |
| Aug 18, 2025 | Robert M Gutkowski
Director
|
Sell | 18.3K | $351.5K |
| Aug 18, 2025 | Leslie Bernhard
Director
|
Sell | 18.3K | $351.4K |
| Aug 18, 2025 | Obie Mckenzie
Director
|
Sell | 18.3K | $351.4K |
| Jul 24, 2025 | Leslie Bernhard
Director
|
Grant | 31.7K | - |
| Jul 24, 2025 | Robert M Gutkowski
Director
|
Grant | 31.7K | - |
| Jul 24, 2025 | Obie Mckenzie
Director
|
Grant | 31.7K | - |
| Jun 30, 2025 | Leslie Bernhard
Director
|
Grant | 5.6K | - |
| Jun 30, 2025 | Leslie Bernhard
Director
|
Grant | 5.6K | - |
| Jun 30, 2025 | Robert Michael Delucia
Chief Financial Officer
|
Grant | 6.3K | - |
| Jun 30, 2025 | Robert Michael Delucia
Chief Financial Officer
|
Grant | 6.3K | - |
| Jun 30, 2025 | Robert M Gutkowski
Director
|
Grant | 5.6K | - |
| Jun 30, 2025 | Robert M Gutkowski
Director
|
Grant | 5.6K | - |
| Jun 30, 2025 | Obie Mckenzie
Director
|
Grant | 5.6K | - |
| Jun 30, 2025 | Obie Mckenzie
Director
|
Grant | 5.6K | - |
| Jun 30, 2025 | Rob Phythian
Chief Executive Officer
|
Grant | 6.3K | - |
| Jun 30, 2025 | Rob Phythian
Chief Executive Officer
|
Grant | 6.3K | - |
| May 30, 2025 | Robert Michael Delucia
Chief Financial Officer
|
Buy | 7.4K | $570.6K |
| May 30, 2025 | Joseph Michael Lubin
Director
|
Grant | 1.2M | $88.6M |
| May 30, 2025 | Rob Phythian
Chief Executive Officer
|
Buy | 44.6K | $3.4M |
Source: TwelveData, from SEC Form 4 filings
SBET stock forecast: questions people ask
Answered from the figures on this page, as of October 26, 2026.